Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are recommended only if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection. In 2017, the global Anti-Venom market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Anti-Venom market based on company, product type, application and key regions. This report studies the global market size of Anti-Venom in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Anti-Venom in these regions. This research report categorizes the global Anti-Venom market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis. The various contributors involved in the value chain of Anti-Venom include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Anti-Venom include Medtoxin Venom Laboratories Institute of Immunology Alomone Labs Sigma Aldrich Wyeth Pharmaceuticals Protherics PLC Bharat Serums and Vaccines Butantan Institute Haffkine Bio-Pharmaceutical Corporation Micropaharm Limited Market Size Split by Type Cytotoxic Neurotoxic Haemotoxic Cardiotoxic Myotoxic Market Size Split by Application Snake Spider Scorpion Market size split by Region North America United States Canada Mexico Asia-Pacific China India Japan South Korea Australia Indonesia Singapore Malaysia Philippines Thailand Vietnam Europe Germany France UK Italy Spain Russia Central & South America Brazil Rest of Central & South America Middle East & Africa GCC Countries Turkey Egypt South Africa The study objectives of this report are: To study and analyze the global Anti-Venom market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025. To understand the structure of Anti-Venom market by identifying its various subsegments. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). Focuses on the key global Anti-Venom manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Anti-Venom with respect to individual growth trends, future prospects, and their contribution to the total market. To project the value and volume of Anti-Venom submarkets, with respect to key regions (along with their respective key countries). To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. To strategically profile the key players and comprehensively analyze their growth strategies. In this study, the years considered to estimate the market size of Anti-Venom are as follows: History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2025 This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Anti-Venom market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources. For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents 1 Study Coverage 1.1 Anti-Venom Product 1.2 Key Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global Anti-Venom Market Size Growth Rate by Type 1.4.2 Cytotoxic 1.4.3 Neurotoxic 1.4.4 Haemotoxic 1.4.5 Cardiotoxic 1.4.6 Myotoxic 1.5 Market by Application 1.5.1 Global Anti-Venom Market Size Growth Rate by Application 1.5.2 Snake 1.5.3 Spider 1.5.4 Scorpion 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Anti-Venom Market Size 2.1.1 Global Anti-Venom Revenue 2016-2025 2.1.2 Global Anti-Venom Sales 2016-2025 2.2 Anti-Venom Growth Rate by Regions 2.2.1 Global Anti-Venom Sales by Regions 2.2.2 Global Anti-Venom Revenue by Regions 3 Breakdown Data by Manufacturers 3.1 Anti-Venom Sales by Manufacturers 3.1.1 Anti-Venom Sales by Manufacturers 3.1.2 Anti-Venom Sales Market Share by Manufacturers 3.1.3 Global Anti-Venom Market Concentration Ratio (CR5 and HHI) 3.2 Anti-Venom Revenue by Manufacturers 3.2.1 Anti-Venom Revenue by Manufacturers (2016-2018) 3.2.2 Anti-Venom Revenue Share by Manufacturers (2016-2018) 3.3 Anti-Venom Price by Manufacturers 3.4 Anti-Venom Manufacturing Base Distribution, Product Types 3.4.1 Anti-Venom Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Anti-Venom Product Category 3.4.3 Date of International Manufacturers Enter into Anti-Venom Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type 4.1 Global Anti-Venom Sales by Type 4.2 Global Anti-Venom Revenue by Type 4.3 Anti-Venom Price by Type 5 Breakdown Data by Application 5.1 Overview 5.2 Global Anti-Venom Breakdown Data by Application 6 North America 6.1 North America Anti-Venom by Countries 6.1.1 North America Anti-Venom Sales by Countries 6.1.2 North America Anti-Venom Revenue by Countries 6.1.3 United States 6.1.4 Canada 6.1.5 Mexico 6.2 North America Anti-Venom by Type 6.3 North America Anti-Venom by Application 6.4 North America Anti-Venom by Company 7 Europe 7.1 Europe Anti-Venom by Countries 7.1.1 Europe Anti-Venom Sales by Countries 7.1.2 Europe Anti-Venom Revenue by Countries 7.1.3 Germany 7.1.4 France 7.1.5 UK 7.1.6 Italy 7.1.7 Russia 7.2 Europe Anti-Venom by Type 7.3 Europe Anti-Venom by Application 7.4 Europe Anti-Venom by Company 8 Asia Pacific 8.1 Asia Pacific Anti-Venom by Countries 8.1.1 Asia Pacific Anti-Venom Sales by Countries 8.1.2 Asia Pacific Anti-Venom Revenue by Countries 8.1.3 China 8.1.4 Japan 8.1.5 Korea 8.1.6 India 8.1.7 Australia 8.1.8 Indonesia 8.1.9 Malaysia 8.1.10 Philippines 8.1.11 Thailand 8.1.12 Vietnam 8.1.13 Singapore 8.2 Asia Pacific Anti-Venom by Type 8.3 Asia Pacific Anti-Venom by Application 8.4 Asia Pacific Anti-Venom by Company 9 Central & South America 9.1 Central & South America Anti-Venom by Countries 9.1.1 Central & South America Anti-Venom Sales by Countries 9.1.2 Central & South America Anti-Venom Revenue by Countries 9.1.3 Brazil 9.2 Central & South America Anti-Venom by Type 9.3 Central & South America Anti-Venom by Application 9.4 Central & South America Anti-Venom by Company 10 Middle East and Africa 10.1 Middle East and Africa Anti-Venom by Countries 10.1.1 Middle East and Africa Anti-Venom Sales by Countries 10.1.2 Middle East and Africa Anti-Venom Revenue by Countries 10.1.3 GCC Countries 10.1.4 Turkey 10.1.5 Egypt 10.1.6 South Africa 10.2 Middle East and Africa Anti-Venom by Type 10.3 Middle East and Africa Anti-Venom by Application 10.4 Middle East and Africa Anti-Venom by Company 11 Company Profiles 11.1 Medtoxin Venom Laboratories 11.1.1 Medtoxin Venom Laboratories Company Details 11.1.2 Company Description 11.1.3 Sales, Revenue and Gross Margin of Anti-Venom 11.1.4 Anti-Venom Product Description 11.1.5 Recent Development 11.2 Institute of Immunology 11.2.1 Institute of Immunology Company Details 11.2.2 Company Description 11.2.3 Sales, Revenue and Gross Margin of Anti-Venom 11.2.4 Anti-Venom Product Description 11.2.5 Recent Development 11.3 Alomone Labs 11.3.1 Alomone Labs Company Details 11.3.2 Company Description 11.3.3 Sales, Revenue and Gross Margin of Anti-Venom 11.3.4 Anti-Venom Product Description 11.3.5 Recent Development 11.4 Sigma Aldrich 11.4.1 Sigma Aldrich Company Details 11.4.2 Company Description 11.4.3 Sales, Revenue and Gross Margin of Anti-Venom 11.4.4 Anti-Venom Product Description 11.4.5 Recent Development 11.5 Wyeth Pharmaceuticals 11.5.1 Wyeth Pharmaceuticals Company Details 11.5.2 Company Description 11.5.3 Sales, Revenue and Gross Margin of Anti-Venom 11.5.4 Anti-Venom Product Description 11.5.5 Recent Development 11.6 Protherics PLC 11.6.1 Protherics PLC Company Details 11.6.2 Company Description 11.6.3 Sales, Revenue and Gross Margin of Anti-Venom 11.6.4 Anti-Venom Product Description 11.6.5 Recent Development 11.7 Bharat Serums and Vaccines 11.7.1 Bharat Serums and Vaccines Company Details 11.7.2 Company Description 11.7.3 Sales, Revenue and Gross Margin of Anti-Venom 11.7.4 Anti-Venom Product Description 11.7.5 Recent Development 11.8 Butantan Institute 11.8.1 Butantan Institute Company Details 11.8.2 Company Description 11.8.3 Sales, Revenue and Gross Margin of Anti-Venom 11.8.4 Anti-Venom Product Description 11.8.5 Recent Development 11.9 Haffkine Bio-Pharmaceutical Corporation 11.9.1 Haffkine Bio-Pharmaceutical Corporation Company Details 11.9.2 Company Description 11.9.3 Sales, Revenue and Gross Margin of Anti-Venom 11.9.4 Anti-Venom Product Description 11.9.5 Recent Development 11.10 Micropaharm Limited 11.10.1 Micropaharm Limited Company Details 11.10.2 Company Description 11.10.3 Sales, Revenue and Gross Margin of Anti-Venom 11.10.4 Anti-Venom Product Description 11.10.5 Recent Development 12 Market Opportunities, Challenges, Risks and Influences Factors Analysis 12.1 Market Opportunities and Drivers 12.2 Market Challenges 12.3 Market Risks/Restraints 12.4 Key World Economic Indicators 13 Value Chain and Sales Channels Analysis 13.1 Value Chain Analysis 13.1.1 Typical Suppliers of Key Anti-Venom Raw Material 13.1.2 Anti-Venom Customers 13.2 Sales Channels Analysis 13.2.1 Sales Channels Analysis 13.2.2 Distributors 14 Research Findings and Conclusion 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 188.8.131.52 Research Programs/Design 184.108.40.206 Market Size Estimation 220.127.116.11 Market Breakdown and Data Triangulation 15.1.2 Data Source 18.104.22.168 Secondary Sources 22.214.171.124 Primary Sources 15.2 Author Details 15.3 Disclaimer